Paradigm Biocapital Advisors »

Zentalis Pharmaceuticals shares owned by Paradigm Biocapital Advisors

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Paradigm Biocapital Advisors from 13F filings

Historical chart of Paradigm Biocapital Advisors investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Paradigm Biocapital Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.1M 400k 15.15
2022-03-31 $13M 288k 46.14
2021-12-31 $25M 300k 84.06